8-144515746-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_004260.4(RECQL4):c.1258+18G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.46 in 1,610,022 control chromosomes in the GnomAD database, including 175,331 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.40 ( 13513 hom., cov: 34)
Exomes 𝑓: 0.47 ( 161818 hom. )
Consequence
RECQL4
NM_004260.4 intron
NM_004260.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.296
Publications
24 publications found
Genes affected
RECQL4 (HGNC:9949): (RecQ like helicase 4) The protein encoded by this gene is a DNA helicase that belongs to the RecQ helicase family. DNA helicases unwind double-stranded DNA into single-stranded DNAs and may modulate chromosome segregation. This gene is predominantly expressed in thymus and testis. Mutations in this gene are associated with Rothmund-Thomson, RAPADILINO and Baller-Gerold syndromes. [provided by RefSeq, Jan 2010]
RECQL4 Gene-Disease associations (from GenCC):
- Baller-Gerold syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, G2P, Orphanet
- Rothmund-Thomson syndromeInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Rothmund-Thomson syndrome type 2Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P
- osteosarcomaInheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
- rapadilino syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 8-144515746-C-T is Benign according to our data. Variant chr8-144515746-C-T is described in ClinVar as Benign. ClinVar VariationId is 94884.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.563 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| RECQL4 | NM_004260.4 | c.1258+18G>A | intron_variant | Intron 6 of 20 | ENST00000617875.6 | NP_004251.4 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| RECQL4 | ENST00000617875.6 | c.1258+18G>A | intron_variant | Intron 6 of 20 | 1 | NM_004260.4 | ENSP00000482313.2 |
Frequencies
GnomAD3 genomes AF: 0.396 AC: 60246AN: 152020Hom.: 13508 Cov.: 34 show subpopulations
GnomAD3 genomes
AF:
AC:
60246
AN:
152020
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.475 AC: 115771AN: 243622 AF XY: 0.480 show subpopulations
GnomAD2 exomes
AF:
AC:
115771
AN:
243622
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.467 AC: 680732AN: 1457884Hom.: 161818 Cov.: 50 AF XY: 0.471 AC XY: 341381AN XY: 724960 show subpopulations
GnomAD4 exome
AF:
AC:
680732
AN:
1457884
Hom.:
Cov.:
50
AF XY:
AC XY:
341381
AN XY:
724960
show subpopulations
African (AFR)
AF:
AC:
5302
AN:
33452
American (AMR)
AF:
AC:
24316
AN:
44334
Ashkenazi Jewish (ASJ)
AF:
AC:
11319
AN:
26046
East Asian (EAS)
AF:
AC:
16479
AN:
39596
South Asian (SAS)
AF:
AC:
48327
AN:
85882
European-Finnish (FIN)
AF:
AC:
25621
AN:
51980
Middle Eastern (MID)
AF:
AC:
2057
AN:
5758
European-Non Finnish (NFE)
AF:
AC:
519965
AN:
1110584
Other (OTH)
AF:
AC:
27346
AN:
60252
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
20256
40512
60769
81025
101281
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
15356
30712
46068
61424
76780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.396 AC: 60267AN: 152138Hom.: 13513 Cov.: 34 AF XY: 0.403 AC XY: 29989AN XY: 74342 show subpopulations
GnomAD4 genome
AF:
AC:
60267
AN:
152138
Hom.:
Cov.:
34
AF XY:
AC XY:
29989
AN XY:
74342
show subpopulations
African (AFR)
AF:
AC:
7217
AN:
41540
American (AMR)
AF:
AC:
7810
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
AC:
1454
AN:
3472
East Asian (EAS)
AF:
AC:
2420
AN:
5162
South Asian (SAS)
AF:
AC:
2804
AN:
4826
European-Finnish (FIN)
AF:
AC:
5294
AN:
10578
Middle Eastern (MID)
AF:
AC:
124
AN:
294
European-Non Finnish (NFE)
AF:
AC:
31996
AN:
67932
Other (OTH)
AF:
AC:
903
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1770
3540
5309
7079
8849
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
570
1140
1710
2280
2850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1877
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
May 08, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Rapadilino syndrome Benign:2
Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Feb 01, 2025
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:2
Jun 29, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Rothmund-Thomson syndrome type 2 Benign:2
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Baller-Gerold syndrome Benign:2
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.